Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acceptability of Pentasa Sachets vs Pentasa 500 mg Tablets in Children with Crohn's Disease
2004-002802-31Phase 4Completed
- Sponsor
- Ferring-Leciva
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Salcrozine in Crohn's disease (2 arms), sponsored by Ferring-Leciva. Primary endpoint: Acceptability parameters. Started Dec 2004; status: completed.
02
Drugs
Salcrozine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2004-002802-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002802-31.